U.S. health regulators informed senior executives at Merck, Sanofi and AstraZeneca last week that their approved protective RSV treatments for infants would face fresh safety scrutiny following ...
Anheuser-Busch InBev (NYSE: BUD) is confronting a major shift in the alcohol industry. A new generation of consumers is ...